October 19, 2023

Members briefed on US report on COVID diagnostics and therapeutics, TRIPS flexibilities

On 19 October, the United States International Trade Commission (USITC) provided a briefing to WTO members on its report “COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities”. The report, released on 17 October, had been requested by the US Trade Representative (USTR) to provide information on market dynamics of COVID-19 diagnostics and therapeutics in the context of discussions under paragraph 8 of the 12th Ministerial Conference (MC12) Decision on the Agreement on Trade-related Aspects of Intellectual Property Rights (TRIPS).

All copyrights for this article are reserved to WTO news

E-NEWSLETTER
Share This